| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5665071 | IMPAX | Reloadable automatic or manual emergency injection system |
May, 2013
(10 years ago) | |
| US10166334 | IMPAX | Medicine injection apparatuses |
Jan, 2025
(9 months from now) | |
| US10166344 | IMPAX | Injection needle assembly |
Jan, 2025
(9 months from now) | |
| US7905352 | IMPAX | Kits containing medicine injection devices and containers |
Apr, 2027
(2 years from now) | |
Adrenaclick is owned by Impax.
Adrenaclick contains Epinephrine.
Adrenaclick has a total of 4 drug patents out of which 1 drug patent has expired.
Expired drug patents of Adrenaclick are:
- US5665071
Adrenaclick was authorised for market use on 25 November, 2009.
Adrenaclick is available in injectable;intramuscular, subcutaneous dosage forms.
The generics of Adrenaclick are possible to be released after 12 April, 2027.
Drugs and Companies using EPINEPHRINE ingredient
Market Authorisation Date: 25 November, 2009
Treatment: NA
Dosage: INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS
More Information on Dosage
ADRENACLICK family patents
